Filtered By:
Drug: Magnesium
Procedure: Percutaneous Coronary Intervention
This page shows you your search results in order of date.
Order by Relevance | Date
Total 80 results found since Jan 2013.
Biodegradable Polymer DES (Ultimaster) vs. Magnesium Bioresorbable Scaffold (BRS Magmaris) in Diabetic Population with NSTE-ACS: A One-Year Clinical Outcome of Two Sirolimus-Eluting Stents
CONCLUSION: Both, Ultimaster and Magmaris revealed relative safety and efficiency at a one-year follow-up in the diabetic population in ACS settings. The observed rates of TLF were low, which combined with a lack of in-stent thrombosis suggests that both investigated devices might be an interesting therapeutic option for diabetics with ACS. Nevertheless, further large randomized clinical trials are needed to confirm fully our results.PMID:34859105 | PMC:PMC8632392 | DOI:10.1155/2021/8636050
Source: Atherosclerosis - December 3, 2021 Category: Cardiology Authors: Piotr Rola Adrian W łodarczak Mateusz Barycki Marek Szudrowicz Magdalena Łanocha Jan Jakub Kulczycki Karol Turkiewicz Katarzyna Wo źnica Maciej Lesiak Adrian Doroszko Source Type: research
Retrospective analysis of renal prognosis in elderly coronary artery disease patients complicated with renal insufficiency
CONCLUSIONS: In the elderly coronary artery disease patients who had renal insufficiency, antiplatelet agents and statin have non-adverse effects on renal function; lower medication rate of renin-angiotensin blocker were found in patients with either worsening renal function or heart failure. Anemia, malnutrition and worsening cardiac function are risk factors of renal function deterioration and mortality.PMID:34606471 | DOI:10.18632/aging.203579
Source: Aging - October 4, 2021 Category: Biomedical Science Authors: Jun Li Fa-Hu Liu Jing Guo Ya-Fen Yu Chun-Qing Li Source Type: research
Serum magnesium concentration may predict no-reflow phenomenon in primary angioplasty for ST-elevation myocardial infarction
Magnes Res. 2020 Nov 1;33(4):123-130. doi: 10.1684/mrh.2021.0477.ABSTRACTNo-reflow phenomenon is a serious complication of percutaneous coronary intervention. Magnesium may play a role in pathogenesis of no-reflow phenomenon since it interacts with processes like platelet inhibition and endothelial-dependent vasodilatation. Relationship of serum magnesium concentration at admission and angiographic no-reflow phenomenon in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is investigated in the present study. A total of 2.248 consecutive patients with ST elevation myocardial i...
Source: Magnesium Research - March 8, 2021 Category: Biochemistry Authors: Eser A çıkgöz Sad ık Kadri Açıkgöz G ökhan Çiçek Source Type: research
